Rapid detection of Staphylococcus aureus using bioluminescent enzyme immunoassay

Area of Science:

• Biochemistry
• Microbiology
• Assay Development

Background:

• Staphylococcus aureus is a significant human pathogen.
• Accurate and rapid detection methods are crucial for clinical diagnostics and food safety.
• Protein A is a unique surface protein found in Staphylococcus aureus.

Purpose of the Study:

• To develop a sensitive and specific bioluminescent enzyme immunoassay (BLEIA) for detecting protein A-bearing Staphylococcus aureus.
• To evaluate the detection limit and specificity of the developed BLEIA method.

Main Methods:

• Development of a BLEIA using biotinylated firefly luciferase.
• Testing the assay with various concentrations of purified protein A.
• Evaluating the assay's performance against different strains of Staphylococcus aureus and other bacteria.
• Assessing the detection of Staphylococcus aureus in human samples after short cultivation periods.

Main Results:

• The BLEIA detected protein A at concentrations as low as 1 pg/mL.
• The assay identified Staphylococcus aureus at 10^3 colony-forming units (cfu)/mL.
• Significant signals were observed for all 24 tested Staphylococcus aureus strains.
• No significant signals were detected for 44 strains of coagulase-negative staphylococci and other bacterial genera.
• The BLEIA successfully detected Staphylococcus aureus from human samples after 5 hours of cultivation, starting from approximately 50 cfu/mL.

Conclusions:

• The developed BLEIA offers a highly sensitive and specific method for detecting Staphylococcus aureus.
• This assay can effectively differentiate Staphylococcus aureus from other bacterial species.
• The method shows potential for rapid and reliable detection of Staphylococcus aureus in clinical and environmental settings.